Global Virus Filtration market growth 2024, Forecast To 2033

The virus filtration market has demonstrated rapid growth, increasing from$4.88 billion in 2023 to$5.45 billion in 2024, with a compound annual growth rate (CAGR) of 11.7%. This growth in the historic period is attributed to the rise in biopharmaceutical production, growing incidence of viral contaminations, global expansion of biopharmaceutical companies, awareness of viral safety, focus on monoclonal antibody production, demand for single-use systems, increased biomanufacturing capacities, and integration of continuous manufacturing. Looking ahead, the market is anticipated to witness rapid growth, reaching$8.71 billion in 2028, with a CAGR of 12.4%. Factors driving this growth include growth in vaccine production, preparedness for emerging viral threats, expansion of cell and gene therapy, increasing demand for biosimilars, development of high-throughput systems, focus on point-of-use filtration, continuous improvement in product design, flexibility in bioprocessing workflows. Major trends in the forecast period include technological convergence with nanotechnology, integration of artificial intelligence (AI), sustainable filtration technologies, customized filtration solutions, disposable filtration technologies, integration of automation, increased R&D investments, and technological partnerships and collaborations.